Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Trevena Inc (TRVN)

Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trevena Inc 955 Chesterbrook Boulevard Suite 110 Chesterbrook PA 19087 USA

www.trevena.com P: 610-354-8840

Description:

Trevena, Inc. is a biopharmaceutical company. It focuses on discovering and developing therapeutics for G protein coupled receptors. The Company's product pipeline includes TRV027, TRV130, TRV734 and Delta opioid biased ligand which are in different clinical phases. Trevena, Inc. is based in King of Prussia, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 7,559
Enterprise Value, $K 5,389
Shares Outstanding, K 18,321
Annual Sales, $ 3,130 K
Annual Net Income, $ -40,290 K
Last Quarter Sales, $ 180 K
Last Quarter Net Income, $ -7,930 K
EBIT, $ -34,500 K
EBITDA, $ -34,170 K
60-Month Beta 1.11
% of Insider Shareholders 2.40%
% of Institutional Shareholders 13.56%
Float, K 17,881
% Float 97.60%
Short Volume Ratio 0.35

Growth:

1-Year Return -37.02%
3-Year Return -98.99%
5-Year Return -98.96%
5-Year Revenue Growth -45.38%
5-Year Earnings Growth 69.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.06 on 04/01/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -2.80
EPS Growth vs. Prev Qtr -85.96%
EPS Growth vs. Prev Year -45.21%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 11/10/22

TRVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,018.15%
Return-on-Assets % -98.93%
Profit Margin % -1,287.22%
Debt/Equity 8.35
Price/Sales 2.40
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.26
Interest Coverage -10.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar